Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-22

Clinical Trial Update: A Study to Compare the Safety and Effectiveness of a Non-FDA Approved Device Dermal Gel Extra (DGE) and an FDA Approved Device for the Correction of Nasolabial Folds (NLFs) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing Dermal Gel Extra (DGE) to an FDA-approved device for correcting nasolabial folds; the study completed and results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dermal Gel Extra (DGE)
  • FDA Approved Device for Nasolabial Folds

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Facial Wrinkles at the Nasolabial Folds | Phase 3 | Status: COMPLETED | Results posted: 2015-04-22